InflaRx N.V.

InflaRx N.V.verified

IFRX

Price:

$0.94

Market Cap:

$54.94M

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; for the treatment of anti-neutrophil cytoplasm antibody associated vasculitis, a rare and life-threatening autoimmune dis...[Read more]

Industry

Biotechnology

IPO Date

2017-11-07

Stock Exchange

NASDAQ

Ticker

IFRX

The Enterprise Value as of March 2026 (TTM) for InflaRx N.V. (IFRX) is 49.47M

According to InflaRx N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 49.47M. This represents a change of -17.85% compared to the average of 60.21M of the last 4 quarters.

InflaRx N.V. (IFRX) Historical Enterprise Value (quarterly & annually)

How has IFRX Enterprise Value performed in the past?

The mean historical Enterprise Value of InflaRx N.V. over the last ten years is 201.56M. The current 49.47M Enterprise Value has changed 2.35% with respect to the historical average. Over the past ten years (40 quarters), IFRX's Enterprise Value was at its highest in in the March 2019 quarter at 816.62M. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

201.56M

Median

118.02M

Minimum

42.72M

Maximum

740.49M

InflaRx N.V. (IFRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of InflaRx N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 170.04%

Maximum Annual Enterprise Value = 740.49M

Minimum Annual Increase = -91.96%

Minimum Annual Enterprise Value = 42.72M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202542.72M-65.26%
2024122.97M77.26%
202369.37M-38.65%
2022113.08M-24.33%
2021149.44M73.82%
202085.98M44.40%
201959.54M-91.96%
2018740.49M170.04%
2017274.22M-23.36%
2016357.79M4.99%

InflaRx N.V. (IFRX) Average Enterprise Value

How has IFRX Enterprise Value performed in the past?

The current Enterprise Value of InflaRx N.V. (IFRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

78.35M

5-year avg

99.52M

10-year avg

201.56M

InflaRx N.V. (IFRX) Enterprise Value vs. Peers

How is IFRX’s Enterprise Value compared to its peers?

InflaRx N.V.’s Enterprise Value is less than Shattuck Labs, Inc. (245.35M), less than Connect Biopharma Holdings Limited (114.53M), greater than ImageneBio Inc (38.67M), greater than Kalaris Therapeutics Inc (26.27M), less than Artiva Biotherapeutics, Inc. (115.73M), less than Sutro Biopharma, Inc. (127.79M), greater than Quince Therapeutics, Inc. (16.00M), less than Metagenomi, Inc. Common Stock (52.36M), less than Context Therapeutics Inc. (187.81M), less than aTyr Pharma, Inc. (80.54M),

Build a custom stock screener for InflaRx N.V. (IFRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InflaRx N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InflaRx N.V. (IFRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InflaRx N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is InflaRx N.V.'s Enterprise Value?

What is the highest Enterprise Value for InflaRx N.V. (IFRX)?

What is the 3-year average Enterprise Value for InflaRx N.V. (IFRX)?

What is the 5-year average Enterprise Value for InflaRx N.V. (IFRX)?

How does the current Enterprise Value for InflaRx N.V. (IFRX) compare to its historical average?